Globeflex Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.2M	Buy	450,580 +158,372	+54%	+$3.77M	1.69%	5
2025 Q4	$6.82M	Buy	292,208 +1,529	+0.5%	+$34.1K	1.04%	22
2025 Q3	$5.73M	Sell	290,679 -7,408	-2%	-$152K	0.88%	29
2025 Q2	$6.47M	Buy	298,087 +43,901	+17%	+$1.04M	0.54%	43
2025 Q1	$6.16M	Buy	254,186 +59,400	+30%	+$1.34M	0.57%	40
2024 Q4	$4.07M	Buy	194,786 +148,388	+320%	+$3.19M	0.34%	72
2024 Q3	$922K	Sell	46,398 -182,386	-80%	-$3.38M	0.09%	193
2024 Q2	$3.54M	Hold	228,784	–	–	0.37%	65
2024 Q1	$3.65M	Hold	228,784	–	–	0.36%	63
2023 Q4	$3.85M	Sell	228,784 -5,500	-2%	-$75.2K	0.39%	64
2023 Q3	$2.74M	Sell	234,284 -62,212	-21%	-$832K	0.32%	82
2023 Q2	$3.98M	Sell	296,496 -7,695	-3%	-$111K	0.44%	66
2023 Q1	$5.04M	Sell	304,191 -44	-0%	-$726	0.62%	37
2022 Q4	$5.66M	Sell	304,235 -58	-0%	-$893	0.72%	32
2022 Q3	$3.9M	Sell	304,293 -222	-0.1%	-$2.63K	0.67%	27
2022 Q2	$2.13M	Hold	304,515	–	–	0.52%	39
2022 Q1	$2.52M	Hold	304,515	–	–	0.51%	38
2021 Q4	$2.06M	Hold	304,515	–	–	0.42%	55
2021 Q3	$1.61M	Sell	304,515 -306,592	-50%	-$1.68M	0.35%	72
2021 Q2	$3.51M	Buy	611,107 +616	+0.1%	+$3.18K	0.63%	23
2021 Q1	$2.81M	Buy	610,491 +234,284	+62%	+$931K	0.51%	45
2020 Q4	$1.26M	Buy	+376,207	New	+$1.26M	0.27%	121